SH
About
Sinopharm is the largest Chinese medical and healthcare group directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), with the most complete industrial chain coverage and strongest comprehensive competence in China. Its core business includes distribution, retail, scientific research and manufacture of healthcare-related products, and it owns 11 wholly-owned or holding subsidiaries and 6 listed companies.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 1,074 investors are based in Shanghai, Shanghai, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Shanghai, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Sinopharm
Search Investors